INS and diabetes mellitus: This progresses to stage 2 T1D (multiple islet autoantibodies and dysglycemia) and ultimately stage 3 T1D (meet American Diabetes Association (ADA) criteria for diabetes, usually with onset of clinical symptoms, typically requiring treatment with exogenous insulin)2.